Position in LLY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,251,005
+$299,044 QoQ
Shares Held
1,043
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#2,928
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Newman Dignan & Sheerar, Inc. holds $16,082,023 across 8 Drug Manufacturers - General names. LLY ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,236 | $5,393,306 | |
| 2 | MRK |
Merck & Co., Inc.
|
28,738 | $3,692,833 | |
| 3 | AMGN |
Amgen Inc
|
7,582 | $2,745,593 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
1,043 | $1,251,005 | |
| 5 | ABBV |
AbbVie Inc.
|
4,147 | $1,043,551 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
17,344 | $999,361 | |
| 7 | NVS |
Novartis AG
|
3,499 | $548,363 | |
| 8 | PFE |
Pfizer Inc
|
16,944 | $408,011 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,251,005 | 1,043 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $951,961 | 1,035 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,091,874 | 1,016 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $775,208 | 1,016 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $799,797 | 1,026 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $995,221 | 1,205 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,018,268 | 1,319 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,175,642 | 1,327 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,230,411 | 1,359 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,085,254 | 1,395 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $862,721 | 1,480 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $741,239 | 1,380 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $647,192 | 1,380 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $473,919 | 1,380 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $507,054 | 1,386 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $464,007 | 1,435 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $463,648 | 1,430 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $409,509 | 1,430 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $394,994 | 1,430 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $330,401 | 1,430 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $282,309 | 1,230 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $303,022 | 1,622 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $273,858 | 1,622 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $240,088 | 1,622 | Shares | Sole | 2020-10-14 | |
| 2020-03-31 | $191,433 | 1,380 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||